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Abstract
Like most cellular RNA enzymes, the bI5 group I intron requires binding by a protein cofactor to
fold correctly. Here, we use single-molecule approaches to monitor the structural dynamics of the
bI5 RNA in real time as it assembles with its CBP2 protein cofactor. These experiments show that
CBP2 binds to the target RNA in two distinct modes with apparently opposite effects: a “nonspecific”
mode that forms rapidly and induces large conformational fluctuations in the RNA, and a “specific”
mode that forms slowly and stabilizes the native RNA structure. The bI5 RNA folds though multiple
pathways toward the native state, typically traversing dynamic intermediate states induced by
nonspecific binding of CBP2. These results suggest that the protein cofactor-assisted RNA folding
involves sequential nonspecific and specific protein-RNA interactions. The nonspecific interaction
increases the local concentration of CBP2 and the number of conformational states accessible to the
RNA, potentially promoting the formation of specific RNA-protein interactions.
Introduction
Ribonucleoprotein (RNP) complexes catalyze many essential cellular reactions, including
important examples such as protein synthesis and messenger RNA processing. In these RNPs,
the catalytic site is often formed by the RNA while the protein cofactors play auxiliary
roles1. These enzymatic RNAs must fold to specific structures to function properly. In vitro,
RNA folding tend to be difficult for two reasons: the energy landscape of the RNA is rugged
with kinetic traps that prevent efficient folding or the active state of the RNA is only marginally
stable2-15. In cells, these difficulties are mitigated in part by the association of RNA with
protein cofactors that facilitate RNA folding12-15.
Proteins appear to facilitate the folding of RNA via two broad mechanisms12,13. In the first
mechanism, proteins interact nonspecifically with the RNA and promote RNA folding by
resolving non-native conformations, in a way analogous to chaperones acting on misfolded
proteins13,16,17. The nonspecific nature of these RNA-protein interactions may also inhibit
RNA folding under certain conditions, by disrupting native RNA structures as well as
misfolded ones. In a second mechanism, a specific protein cofactor binds to well-defined
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structural features of its target RNA, stabilizing the native RNA structure. If the protein cofactor
binds to the RNA at an early step in the folding pathway, the protein may effectively nucleate
subsequent RNA folding11,18. Alternatively, the protein cofactor may capture and stabilize a
transiently formed RNA native structure, rather than actively inducing structural changes in
the RNA, a mechanism referred to as tertiary structure capture. This has been thought to be the
mechanism by which CBP2 facilitates the folding of the yeast mitochondrial bI5 group I
intron19,20. A protein cofactor may also facilitate RNA folding by a mechanism that exhibits
features of both tertiary structure nucleation or capture21,22. An RNA molecule could also
rely on both a chaperone and a distinct specific cofactor working in concert to accomplish
efficient folding23. The level of complexity observed for protein-facilitated RNA folding
makes the acquisition of real-time information on folding dynamics critical for a
comprehensive understanding of folding mechanisms.
In this work, we use fluorescence resonance energy transfer (FRET)24,25 to investigate the
real-time folding dynamics of RNP complexes at the single-molecule level. It has been shown
previously that single-molecule FRET can be used to detect conformational changes in a small
3-helix junction of ribosomal RNA induced by a specific ribosomal protein and in a DNA
stemloop induced by a RNA chaperone26,27. A useful property of the single-molecule
approach is its ability to detect non-accumulative folding intermediates and multiple folding
pathways that are potentially difficult to detect in ensemble measurements6,28-31. Here, we
report a dynamic structure of the RNA (the bI5 group I intron) and two binding modes between
the RNA and its protein cofactor CBP2. While the specific CBP2-RNA binding mode stabilizes
native RNA structures, the nonspecific binding mode of CBP2 causes large conformational
fluctuations in the RNA. Before attaining its native structure, the bI5 RNA folds through
fluctuating intermediate states induced by nonspecific CBP2 binding. These results suggest a
complex assembly mechanism that involves both nonspecific and specific interactions by a
protein cofactor with its RNA target, which ultimately lead to formation of a well-defined and
active state.
Results
Preparation of bI5 for investigation by single-molecule FRET
The bI5 RNP is comprised of the bI5 group I intron RNA and its CBP2 protein cofactor. The
bI5 RNA exhibits splicing activity, while CBP2 facilitates folding of the RNA10,32-34. The
bI5 RNA spans three major domains: the P5-P4-P6 and P7-P3-P8 domains, which constitute
the conserved catalytic core of all group I introns, and the 5′ domain, which spans helices P1-
P2-P2a (Figure 1a).
To probe the folding of bI5 molecules with FRET, we attached FRET donor (Cy3) and acceptor
(Cy5) dyes near the 5′ and 3′ splice sites, respectively (Figure 1a). The efficiency of energy
transfer from donor to acceptor is sensitive to relative positions of the two dye molecules.
Measurements of the energy transfer efficiency thus allow us to monitor the folding of the
RNA to the native state, which should exhibit a high FRET efficiency due to the close proximity
of the splice sites. In this work, we analyze the bI5 RNA at various Mg2+ concentrations,
primarily focusing on 7 and 40 mM Mg2+. Distinct structures of the RNA were previously
identified at these conditions, facilitating the assignment of observed FRET values to specific
structural states of the bI5 RNA10,35. To follow conformational dynamics of individual
molecules in real time, the RNA was immobilized through a DNA tether to a surface via a
biotin-streptavidin linkage. The surface was coated with polyethylene glycol to prevent
nonspecific protein interactions with the surface (see Figure 1 in Supplementary Material)
36. Fluorescence emission from single bI5 RNA molecules was detected using a total-internal-
reflection microscope.
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The labeling scheme allows us to monitor the splicing activity of the CBP2-bI5 RNP. Upon
addition of guanosine monophosphate (GMP) to the pre-folded CBP2-bI5 complex, the 5′ and
3′ exons are spliced together and the Cy3 and Cy5 dyes are brought into close proximity to
yield a high FRET signal (Figure 1a,b). We monitor the splicing reaction of individual surface-
immobilized RNP complexes and measure the rate of accumulation of the splice product. The
observed reaction rate and extent are in quantitative agreement with those obtained from
ensemble solution-phase measurements of bI5 RNPs (Figure 2a,b). These rates are also similar
to the splicing rate for constructs without dyes, but moderately faster than the rate of the
unmodified RNP lacking the DNA tether (Figure 2c), suggesting that hybridization with the
DNA tether removes an interfering effect of the 3′ exon on the splicing activity of the intron.
Together, these results indicate that the surface-tethered RNA construct used here is a good
model system for the bI5 RNA.
Structure and dynamics of the bI5 RNA in the absence of CBP2
In the absence of CBP2, the single-molecule FRET trajectories of the bI5 RNA show stochastic
transitions between two FRET levels (Figure 3). At 7 mM Mg2+, a near-physiological ionic
environment, the two levels are centered at 0.3 and 0.8, respectively (Figure 3a). The
equilibrium constant between the 0.8 and 0.3 levels is 0.12, and the forward and backward
switching rate constants are 0.25 sec-1 and 1.9 sec-1, respectively (see Figure 2 in
Supplementary Material). As the Mg2+ concentration increases, the value of the lower FRET
level increases (Figure 3c) while that of the higher FRET level remains unchanged. The
equilibrium shifts toward the higher FRET state (Figure 3d).
To assign the two folding states of the bI5 RNA, we monitored the FRET signal of both our
primary construct (Figure 1a) and a truncated construct, ΔP1-P2, which lacks the P1-P2 domain
but can fold independently (see Figure 6a)35. The Cy5 positions are identical in the two
constructs; the Cy3 positions are also close in the context of the RNA secondary structure. Like
the original bI5 RNA, FRET trajectories of the ΔP1-P2 construct predominantly dwell at FRET
= 0.3, but now switch to the higher FRET level only rarely. The lower FRET level of the ΔP1-
P2 construct also increases with Mg2+ concentration, with a trend very similar to that observed
for the conformational collapse and core formation of the ΔP1-P2 construct previously
monitored by electrophoretic mobility and size exclusion chromatography previously
(compare filled squares with open circles, Figure 3c)35. From this, we infer that the lower
FRET level corresponds to conformational collapse and core formation of the bI5 RNA.
To identify the structural change associated with the excursions to a higher FRET level (FRET
= 0.8), we mutated the G-U wobble base pair in the P1 helix to a G-C Watson-Crick base pair
(the U-1C mutation). This mutation disrupts a tertiary contact between the P1 helix and the A-
rich loop in the J4/5 region in the catalytic core of the bI5 RNA (Figure 1a)37,38. While
switching between the same high and low levels is still observed, the U-1C mutation shifts the
equilibrium significantly toward the lower FRET level, reducing the equilibrium constant from
0.12 to 0.03 at 7 mM Mg2+. This suggests that the FRET = 0.8 state is at least partially stabilized
by the tertiary interaction between the P1 helix and the bI5 core, and the appearance of this
state is primarily due to the docking of the P1-P2 domain into the bI5 core. Consistent with
this picture, removal of the P1-P2 domain also reduces the equilibrium constant to 0.03 at 7
mM Mg2+.
The above data suggest a structural picture of the collapsed state in which the RNA tends to
form short-lived structures with native-like features. This is consistent with previous results
that the bI5 RNA forms a collapsed state with native-like topology at 7 mM Mg2+ (35,39).
However, in the absence of CBP2, little splicing activity was observed despite prolonged
incubation with GMP (30 min), indicating that the high FRET state observed here is non-native,
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either because the catalytic core is not accurately folded, or because the P1-P2 domain is not
accurately docked with the core.
Two binding modes of CBP2 lead to distinct conformational changes in the RNA
The conformational dynamics of the bI5 RNA change dramatically when CBP2 binds. At 7
mM Mg2+, two types of single-molecule FRET trajectories occur upon binding by CBP2
(Figure 4). The first type (type I) exhibits regular, stepwise transitions between two FRET
levels (Figure 4a). Whereas the higher level remains at 0.8, the lower level is now centered at
0.5, significantly higher than that observed for the CBP2-free RNA at 7 mM Mg2+ (compare
with Figure 3a). The second type (type II) exhibits broad and irregular fluctuations that are no
longer primarily stepwise, but often appear continuous (Figure 4b). While both types of
behavior co-exist among the RNA molecules at very low CBP2 concentrations, the type II
behavior dominates at CBP2 concentrations above 5 nM (Figure 5a). Moreover, the overall
amplitude of type II fluctuations increases with the CBP2 concentration and the FRET values
adopt a very broad distribution ranging from 0.1 to 0.9 at high CBP2 concentrations (Figure
4b). The fluctuations also occur over a wide range of timescales. The autocorrelation spectrum
of the FRET trajectories, which measures the rate of FRET fluctuations, cannot be fit to first-
order kinetics with a single rate constant, but instead spans three orders of magnitude in time,
from 0.05 to 30 s (Figure 4b). The autocorrelation spectrum is independent of the laser intensity
used, indicating that the FRET fluctuations are not due to photophysical effects of the dyes.
When the bI5 RNA is first incubated with a high concentration of CBP2 so that the majority
of FRET trajectories exhibit the type II behavior and is then buffer-exchanged to remove CBP2
in the solution, the FRET trajectories convert to the type I behavior at the relatively slow rate
of 0.04 min-1 (see Figure 3 in Supplementary Material). This conversion rate is far slower
than the FRET fluctuation rates observed in the type II behavior (Figure 4b), suggesting that
type II fluctuations are not due to rapid binding and dissociation of CBP2 from the RNA. This
is also supported by the observation that type II fluctuations persist with similar amplitude for
a sustained period of time after buffer exchange, despite the absence of excess CBP2 available
in the solution to bind the RNA (data not shown). Interestingly, addition of a tRNA or heparin
competitor appears to destabilize type II binding, accelerating the conversion to the type I
behavior by about 10 fold (Supplementary Figure 3). Dissociation of CBP2 bound in type I
mode remains slow. A thorough removal of the stably bound CBP2 by addition of Proteinase
K converts the FRET dynamics to those indicative of CBP2-free RNA, which exhibits stepwise
FRET transitions between 0.3 and 0.8.
These experiments suggest that type I behavior (Figure 4a) is due to strong binding of CBP2,
whereas type II behavior (Figure 4b) is due to weaker and presumably less specific binding by
CBP2 to the RNA, which can be readily disrupted by competitors. In the following, we
operationally refer to type I and II CBP2 binding as “specific” and “nonspecific” binding,
respectively. These two binding modes are not necessarily mutually exclusive. The decreases
in the type I fraction seen at high CBP2 concentrations (Figure 5a) does not necessarily indicate
replacement of specifically bound CBP2 by non-specifically bound CBP2, but instead CBP2
bound in both modes may coexist on the same RNA at these concentrations with the type I
dynamics masked by the type II FRET fluctuations.
Specific binding of CBP2 stabilizes the native tertiary contacts in the bI5 RNA
In the native CBP2-bI5 complex, a single CBP2 protein remains strongly bound to the bI5
RNA molecule in the presence of heparin33. To determine the stoichiometry of the specifically
bound CBP2, we performed a titration of bI5 with CBP2, followed by treatment with heparin
to remove nonspecific binding. The fraction of molecules with type I behavior can be fit with
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a Hill coefficient close to 1 (n = 1.3 ± 0.3, Figure 5b), suggesting that specific binding can be
accounted for by binding of a single CBP2 molecule.
At 7 mM Mg2+, the lower FRET level increases upon specific CBP2 binding from 0.3 to 0.5,
a value similar to the lower FRET level exhibited at 40 mM Mg2+ without CBP2 (compare
Figure 4a with Figure 3b). This is consistent with a previous model suggesting that both CBP2
and high concentrations of Mg2+ tend to promote the formation of the bI5 RNA core10.
Furthermore, the equilibrium constant between the 0.8 and the lower FRET levels increases
from 0.12 to 0.49 upon specific binding of CBP2 (compare Figure 4a with Figure 3a). The
U-1C mutation, which disrupts a tertiary contact between the P1 helix and the bI5 core, reduces
the equilibrium constant from 0.49 to 0.02 (Figure 4a). This mutation also eliminates splicing
activity whereas native sequence CBP2-bI5 complexes are catalytically active at 7 mM
Mg2+ (Figure 2a). We thus infer that the FRET = 0.8 state observed in the specific binding
mode is the native state of the bI5 RNP with the P1-P2 domain docked into the catalytic core
and that the transitions observed between 0.5 and 0.8 FRET levels indicate docking and
undocking of P1-P2. These results show that specific CBP2 binding strongly promotes P1-P2
docking.
Nonspecific binding of CBP2 causes dynamic structural fluctuations in the RNA
The type II binding mode of CBP2 induces broad fluctuations in FRET that span nearly the
entire observable FRET range and a few orders of magnitude in time (Figure 4b). To distinguish
whether these fluctuations report conformational changes in the RNA or changes in the
photophysical properties of the dyes induced by potential interactions of CBP2 with the dyes,
we designed two control bI5 constructs in which the FRET donor and acceptor are linked via
a perfectly base-paired duplex. In these constructs, the inter-dye distance cannot change, thus
changes in FRET arising from conformational changes of the RNA should be eliminated but
potential CBP2-induced changes in the photophysical properties of the dyes should remain
(see Supplemental Material Figure 4). FRET trajectories for both control constructs
demonstrate a steady FRET signal except for abrupt transitions to FRET = 0 caused by blinking
of the acceptor dye, a well-known photophysical phenomenon. Thus, the observed broad FRET
fluctuations between non-zero values (Figure 4b) largely report authentic conformational
dynamics of the bI5 RNA. These results, together with the observation that the FRET
fluctuation rates are much faster than the CBP2 dissociation rate, indicate that the observed
FRET fluctuations are due to conformational fluctuations of the bI5 RNA while CBP2 proteins
remain bound.
Next we evaluate which domains of the RNA fluctuate when bound by CBP2 in the type II
mode. A possible origin for the conformational fluctuations arises from the peripheral domains
P1-P2 and P9-P9.1, which are connected to the catalytic core via relatively long, potentially
flexible, single-stranded regions. To test this idea, we deleted the P1-P2 or P9-P9.1 domains
from the primary construct (Figure 6a,b). In these truncated constructs, we still observe broad,
irregular FRET fluctuations, albeit with fluctuation amplitudes that are moderately smaller
than those observed in the original RNA. Remarkably, even the double-deletion construct bI5
ΔP1-P2 ΔP9-P9.1, which contains only the minimum core spanning the P5-P4-P6 and P7-P3-
P8 domains, exhibits significant CBP2-induced fluctuations (Figure 6c), suggesting that CBP2
possesses a robust ability to induce RNA structural fluctuations.
To determine if binding of CBP2 can disrupt Watson-Crick base pairs, a basic RNA structural
motif, we designed a simple RNA construct that consists of an AU-rich hairpin labeled with a
donor and acceptor (Figure 7). We expect that melting of the hairpin will decrease FRET
efficiencies as the dyes are pulled apart. CBP2-induced fluctuations to lower FRET values are
indeed observed (Figure 7a), whereas a structurally similar control construct with the two dyes
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covalently confined to within 2 nucleotide bases does not exhibit such fluctuations (Figure 7b),
suggesting that CBP2 is capable of melting RNA secondary structures.
The structure-destabilizing properties of nonspecific CBP2 binding suggest that under
conditions where nonspecific binding dominates, native RNA contacts might also be disrupted.
Consistent with this notion, we find that high concentrations of CBP2 partially inhibit splicing
at low Mg2+ concentrations. At 7 mM Mg2+ and 10 nM CBP2, a condition at which most RNA
molecules exhibit nonspecific CBP2 binding (see Figure 5), splicing is 8-fold slower than the
rate measured in the presence of heparin to remove non-specific binding. This inhibitory effect
is not observed at high Mg2+ concentrations.
Binding by CBP2 is fast and follows bimolecular kinetics
The addition of CBP2 to the bI5 RNA changes the RNA conformational dynamics rapidly.
The transition from the two-state behavior of the free RNA to the broad, continuous fluctuation
behavior characteristic of the type II CBP2 binding occurs with a rate constant of 12 min-1
upon addition of 50 nM CBP2 (Figure 8a,b). This binding rate scales linearly with CBP2
concentration (Figure 8c). This result shows that formation of the nonspecific CBP2-bI5 RNA
complex follows simple, concentration-dependent, bimolecular kinetics with a rate constant
close to the diffusion-limit (6 × 108 M-1 min-1).
In contrast, as judged by nitrocellulose filter partitioning, splicing activity, and time resolved
footprinting assays, the assembly of stable, functional bI5 RNPs exhibits slow, protein-
concentration-independent, unimolecular kinetics (0.5 min-1)19,40,41. Even the formation of
a stable, nonfunctional complex between CBP2 and the an expanded, non-native bI5 RNA state
that forms in the absence of Mg2+ follows slow, unimolecular kinetics20. Considering that the
dissociation kinetics of type II binding mode makes it difficult to detect in these bulk assays,
the above results, taken together suggest that formation of the CBP2-bI5 RNA complex occurs
in two major steps: First, a nonspecific CBP2-RNA encounter complex forms via a fast,
bimolecular step and induces substantial conformational fluctuations in the RNA. This rapid
step is then followed by slow formation of a stronger and specific CBP2-bI5 complex.
bI5 folding occurs through multiple pathways and dynamic intermediate states
Next, we investigated the transient assembly dynamics of the bI5 RNA to a native RNP initiated
by a buffer containing high concentrations of Mg2+ (40 mM) and CBP2 (50 nM). Under these
conditions, the bI5 RNA is fully active (Figure 2b). The FRET trajectories dwell predominantly
at a high level of 0.8, and exhibit brief but frequent fluctuations towards lower values at around
0.6 (Figure 9a). The U-1C mutation, which destabilizes the P1-P2 docking and eliminates
splicing activity, greatly reduces the docking equilibrium so that the molecules predominantly
dwell at the lower FRET level of 0.6 (Figure 9b). These observations indicate that the FRET
= 0.8 state observed here is the native state of the bI5 RNA with the P1-P2 domain docked into
the bI5 core.
To observe the folding process in real time, we prepared the bI5 RNA without CBP2 in 7 mM
Mg2+, a condition at which few stable tertiary contacts are formed10,35,39, and initiated
folding by addition of a buffer containing 40 mM Mg2+ and 50 nM CBP2. The majority of
molecules (65%) reach the native state within our observation time, as recognized by a
persistent high FRET level of 0.8 (Figure 9c). Among the molecules that reach a sustained
FRET level of 0.8, 70% exhibit splicing activity, as determined by the assay described in Figure
1. This is consistent with the previously observed fraction (60% - 70%) of bI5 RNPs being
catalytically active, among which about 60% produce splice product and 40% only yield 5′
cleavage product33. Remarkably, before attaining the native state, most molecules traverse a
highly dynamic ensemble of intermediate states (Figure 9c), which exhibit broad, irregular
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fluctuations that are similar to the conformational fluctuations induced by nonspecifically
bound CBP2 at 7 mM Mg2+ (Figure 4b). The bI5 molecules traverse a multitude of pathways
as they fold to the native state, clearly indicated by different transient folding dynamics
observed in individual FRET trajectories. By recording the time at which each molecule
acquires the native state, we obtained a folding time course that is described by at least two
rate constants, 0.5 and 7 min-1 (Figure 9d), further evidence for the existence of multiple folding
pathways. Similar folding kinetics are obtained when the bI5 RNA is pre-incubated with 40
mM Mg2+ before folding is initiated by the addition of 50 nM CBP2 (Figure 9d). This indicates
that the rate-limiting step for bI5 folding is not the structural transition induced by increasing
the Mg2+ concentration from 7 mM to 40 mM, but instead occurs at a later stage during the
protein-dependent folding process. In the presence of heparin to compete with RNA for CBP2
binding, folding kinetics are significantly slower (see Figure 5 in Supplementary Material).
This could result from a reduction in nonspecific bI5-CBP2 binding, which may in turn promote
the RNA folding and the assembly of specific RNA-CBP2 complexes, or from a kinetic
inhibition of specific bI5 RNA-CBP2 interactions directly by heparin.
Discussion
Nearly all cellular RNA enzymes rely on the help of proteins that bind either specifically or
non-specifically in order to function properly. In many cases, the role of these proteins is to
help the catalytic RNA adopt its native structure, rather than to catalyze the underlying
enzymatic reaction. These proteins function in part by altering the conformational dynamics
of the RNA. In this work, we have used single-molecule FRET to monitor the conformational
dynamics of the bI5 RNA prior to binding by the CBP2 cofactor, to probe the conformational
transitions induced by CBP2 binding, and to observe the folding dynamics of the bI5 RNP.
Dynamic structure of the bI5 RNA
FRET trajectories reveal that the conformation of the bI5 RNA is dynamic. Distinct FRET
levels are identified for several folding states of the bI5 RNA10,35. The collapsed state at 7
mM Mg2+ is characterized by FRET = 0.3 (Figure 3a). At lower Mg2+ concentrations where
the RNA populates an expanded state, the FRET value decreases (Figure 3c). At higher
Mg2+ concentrations where the bI5 core exhibits substantial native contacts, FRET is increased
to 0.5 - 0.6 (Figure 3b). Similar FRET is obtained when the core formation is facilitated by
specific binding of CBP2 at 7 mM Mg2+ (Figure 4a). Docking of the P1-P2 domain into the
core yields a FRET = 0.8 (Figures 3a, 3b, 4a and 9a). The docking/undocking transitions of
P1-P2 occur under all conditions, even at high concentrations of Mg2+ and CBP2 where the
bI5 RNA is fully active (Figure 9a) and at low concentrations of Mg2+ without CBP2 where
the bI5 core is not folded and the RNA is inactive (Figure 3a).
Two distinct binding modes of CBP2 to its target RNA
CBP2 binds to its target RNA into distinct modes (Figures 4 and 10). The specific (type I)
binding mode stabilizes the core structure formed between the P5-P4-P6 and P7-P3-P8 domains
of the bI5 RNA and enhances the docking of the P1-P2 domain (Figure 4a). The nonspecific
(type II) mode induces highly dynamic conformational fluctuations within the RNA,
exemplified by fluctuations over a wide range of FRET values and several orders of magnitude
in time scale (Figures 4b, 6). Furthermore, CBP2 has the ability to disrupt Watson-Crick base-
pairs and to induce structural fluctuations in a simple RNA hairpin (Figure 7). These results
indicate that CBP2 possesses an ability to destabilize RNA structures and induce
conformational fluctuations within RNA. The apparent increase in conformational dynamics
(or flexibility) may reflect stabilization of transition states on the RNA energy landscape by
CBP2, which allow the RNA to access conformations that are kinetically inaccessible without
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CBP2. Alternatively, CBP2 may also stabilize the ground conformational states of the RNA
that are otherwise insufficiently stable with dwell time too short for detection.
The protein-assisted bI5 RNA folding involves sequential non-specific and specific binding
of CBP2
Single-molecule experiments show that CBP2 binds to the bI5 RNA rapidly, following
bimolecular kinetics (Figure 8). This rapid association represents a fast-forming encounter
complex mediated by nonspecific, likely electrostatic, interactions. In contrasts, experiments
that preferentially score stable protein-RNA complexes show slow and unimolecular kinetics
for the formation of stable bI5 RNA-CBP2 complex19,20,40. Together, these results support
a new two-step binding model: CBP2 initially binds rapidly and nonspecifically to the RNA;
the conformational rearrangements in the RNA then allow stronger and more specific binding
of CBP2 (Figure 10). As further support for the two-step binding picture, we directly observe
that, at high concentrations of Mg2+ and CBP2, bI5 molecules fold into the native structure via
dynamic intermediates similar to those induced by nonspecific CBP2 binding at lower Mg2+
concentrations (Figure 9c). Also consistent with the nonspecific nature of the initial CBP2
binding, the bI5 molecules traverse multiple pathways as they fold towards the native state
(Figures 9c, d).
While the specific binding mode of CBP2 stabilizes the native state of the bI5 RNA, what role
(s) might the nonspecific binding mode of CBP2 play in the assembly of the RNP? CBP2 has
been previously suggested to assemble with the bI5 RNA via a tertiary-structure capture
mechanism19,20. In this model, the protein cofactor does not direct the RNA to the native
state, but rather binds to and stabilizes the RNA once the tertiary structure has transiently
formed independent of the protein cofactor. Assembly of the native CBP2-bI5 RNP thus
requires the coincidence of two rare events: transient formation of the RNA tertiary structure
and a structurally productive collision between the RNA and the protein. The low probability
of these events occurring simultaneously could pose a challenge in efficient assembly of native
RNP complexes. The rapid, nonspecific binding of CBP2 to the bI5 RNA may alleviate this
difficulty. By confining one or more CBP2 proteins to the vicinity of the RNA, nonspecific
binding effectively increases the local concentration of the protein cofactor, thus could
potentially enhance the collision rate between the protein and the transiently formed RNA
tertiary structure.
When bound nonspecifically, CBP2 also increases the structural dynamics of the bI5 RNA
(Figure 4) and transiently destabilizes RNA secondary structure (Figure 7), as previously
proposed for RNA chaperones13,17. This RNA structural-destabilizing activity likely arises
from the electrostatic interactions between the negatively charged RNA and the positively
charged domains of CBP242, which tend to destabilize RNA-RNA contacts to optimize RNA-
protein contacts. It has been postulated that specific protein cofactors might first use non-
specific electrostatic interactions to destabilize misfolded RNA structures, chaperoning the
RNA to its native state, which is then stabilized by specific protein-RNA interactions17. Our
results demonstrate that a specific protein cofactor can indeed possess an RNA structure
destabilizing capability. Whether CBP2 indeed assist bI5 RNA folding by a chaperone
mechanism in addition to tertiary-structure stabilization awaits further investigation.
Methods
The bI5 RNA and CBP2 protein preparation
All fluorescently labeled RNA constructs consist of three oligonucleotides: an in vitro
transcribed RNA that spans the majority of the bI5 sequence, plus two synthetic RNA or DNA
oligonucleotides (Dharmacon and Qiagen Operon, respectively) labeled with Cy5 or Cy3. One
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of the oligonucleotides is also labeled with biotin to allow surface immobilization. The
sequences used for each DNA or RNA oligo are listed in Table 1 of the Supplemental
Material. Cy3 or Cy5 were either attached to the oligos during synthesis, or post-synthetically
by conjugation of a monoreactive dye (Amersham) to a primary amine group on the
oligonucleotide. For all in vitro transcripts, DNA templates were PCR amplified from plasmid
pTZ18U33 and gel purified. The bI5 RNA transcript was annealed to the two synthetic strands
in 50 mM HEPES pH 7.6, 250 mM KCl and 1% v/v β-mercaptoethanol, and diluted in 40 mM
MgCl2, 50 mM HEPES pH 7.6, 50 mM KCl, 10% w/v glucose, and 200 U/ml RNase inhibitor
(Roche). CBP2 containing a C-terminal (His)6 tag was purified from E. coli by Ni2+-affinity
chromatography, as described33, followed by cation exchange chromatography (Resource S
column, Amersham Biosciences). The protein was dialyzed and stored in 20 mM HEPES (pH
7.6), 200 mM NaCl, 2 mM DTT and 50% (v/v) glycerol.
Surface immobilization of the bI5 RNA
Quartz slides were cleaned using argon plasma (Harrick Scientific), treated with 1% Vectabond
(Vector Laboratories) in acetone, rinsed, and incubated with a 20% (w/v) methoxy-PEG (MW
5,000; Nektar Therapeutics) and 0.2% biotin-PEG (MW 3,400 and 5,000, Nektar Therapeutics)
in 0.1 M sodium bicarbonate (pH 8.4) for at least 3 hours. Streptavidin (0.2 mg/mL, Molecular
Probes) in 50 mM TRIS pH 7.5 and 50 mM NaCl was applied before application of the
biotinylated bI5 RNA diluted to 100 - 500 pM in a solution containing 50 mM HEPES pH 7.6,
50 mM KCl, 10% w/v glucose, and 40 mM MgCl2.
Single-molecule FRET measurements
Donor and acceptor fluorescence from single bI5 molecules were separately resolved using a
total internal reflection microscope, as previously described28. An Andor Ixon 887 back-
illuminated electron multiplying CCD device was used to record the fluorescence image. The
FRET value is defined as IA / (IA + ID), where IA and ID are the fluorescence signals detected
from the acceptor and donor channel, respectively. Unless otherwise noted, all imaging buffers
contained 50 mM KCl, 50 mM HEPES pH 7.6, and 10% w/v glucose, a variable amount of
MgCl2, and an oxygen scavenger system (1% β-mercaptoethanol, 300 μg/mL glucose oxidase,
and 40 μg/mL catalase) to reduce photobleaching. All solutions containing CBP2 also
contained 100 - 200 μg/mL BSA. Measurements were performed at room temperature.
Folding kinetics determination
Folding time for each molecule was defined as the time from addition of the folding buffer to
the start of a stable FRET signal at 0.8 that lasts for at least 100 s. The cumulative folding time
histogram were modeled by a double-exponential decay with two folding rate constants k1 and
k2, and an added contribution from photobleaching (with a rate constant kp), which effectively
biases against slow-folding molecules, as described by the following equation.
(1)
where F is the normalized fraction of molecules folded to the native state, and A1 and A2 are
the relative fractions of molecules exhibit folding rate constants k1 and k2 respectively, with
A1 + A2 = 1. The photobleaching rate kp was independently determined to be 0.06 min-1.
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Splicing was performed by pre-incubating 5 nM fluorescently-labeled bI5 RNA with 50 nM
CBP2 in a buffer containing 50 mM HEPES pH 7.6, 50 mM KCl, 7 or 40 mM MgCl2, 0.1 mg/
mL BSA, and 1% (v/v) β-mercaptoethanol for more than 15 min, before splicing was initiated
by the addition of GMP to 2 mM final concentration. The 15 μL reaction aliquots were
quenched with 5 μL 500 mM EDTA and 100-200 U/mL Proteinase K (Invitrogen). Reaction
products were resolved on a polyacrylamide gel and the Cy5 fluorescence intensities of the
bands were quantified. Measurements of the splicing activity of non-labeled bI5 RNA (either
with the unmodified DNA tether, or without any DNA tether) were performed by re-annealing
Cy5-labeled DNA to the reaction products, for detection using a fluorescence-phosphorescence
imager, after the splicing reaction had been quenched.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The bI5 construct used for single-molecule FRET experiments and its self splicing reaction.
(a) Secondary structure of the bI5 group I intron RNA and its splicing product. Splice sites are
marked with purple triangles. The G-U wobble pair and its interaction with the J4/5 junction
is marked in red. A biotinylated DNA tether is shown in blue. Splicing was initiated by 2 mM
GMP and the resulting close proximity between FRET donor (Cy3) and acceptor (Cy5) in the
spliced product leads to a high FRET efficiency, as shown in (b). After adding a stop solution
containing EDTA and proteinase K, only the spliced products show FRET = 0.9, while the
unspliced RNA molecules show no fluorescence signal due to dissociation of the Cy3-labeled
RNA strand in the absence of Mg2+. Inset: Minimal spliced products observed in the absence
of GMP.
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Similar splicing kinetics for the bI5 RNA as measured by single-molecule and ensemble
measurements. (a) Splicing kinetics in 7 mM Mg2+, 50 nM CBP2 and 2 mM GMP determined
with single surface-immobilized molecules (open circles, FRET assay, 0.9 ± 0.2 min-1) are the
same as those determined for freely diffusing bI5 RNA (closed squares, gel electrophoresis
assay, 1.1 ± 0.1 min-1). Nonspecifically bound and excess CBP2 was removed by addition of
100 μg/mL heparin with the 2 mM GMP. (b) Splicing kinetics measured in 40 mM Mg2+, 50
nM CBP2 determined with single surface-immobilized molecules (open circles, 1.0 ± 0.1
min-1) and with freely diffusing bI5 RNA (closed squares, 0.7 ± 0.1 min-1). No heparin was
added to remove nonspecifically bound CBP2 in this case. (c) Splicing kinetics for four
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different bI5 constructs in 40 mM Mg2+, 50 nM CBP2. The splicing rate constant for the Cy3-
& Cy5-labeled constructs depicted in Figure 1a (open circles, 1.0 ± 0.1 min-1) is similar to that
of a bI5 construct without the Cy3 dye but with Cy5 dye still present on the DNA tether (open
squares, 0.7 ± 0.1 min-1) and for a construct omitting the Cy5 dye from the DNA tether (open
triangles, 0.6 ± 0.2 min-1). The splicing rate constant of a bI5 construct that lacks the DNA
tether is significantly slower (solid triangles, 0.16 ± 0.02 min-1), suggesting that hybridization
of the DNA tether to the 3′ exon removes an interfering effect of the 3′ exon on the splicing
activity of the intron.
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Structural dynamics of the bI5 RNA in the absence of CBP2. (a, b) FRET trajectories of single
molecules (left) and a histogram constructed from many bI5 RNA molecules (right) in 7 and
40 mM Mg2+. In constructing the histogram, a threshold is applied to remove FRET values
associated with either blinking or photobleaching of Cy5. (c) The dependence of the lower
FRET level as a function of Mg2+ concentration for the bI5 (filled triangles) and bI5 ΔP1-P2
(filled squares) constructs. Overlaid is the electrophoretic mobility of the bI5 ΔP1-P2 construct
(open circles)35. (d) Equilibrium constant for the formation of the higher FRET states.
Bokinsky et al. Page 16














CBP2 binds the bI5 RNA in two modes, each inducing distinct conformational dynamics in
the bI5 RNA. (a) Specific binding of CBP2 stabilizes the native structure of the bI5 RNA. Left
panel: FRET trajectory of a bI5 RNA specifically bound to CBP2 in 7 mM Mg2+ showing
regular transitions between FRET levels of 0.5 and 0.8 (type I binding behavior). Center panel:
A FRET histogram of many specific CBP2-bI5 RNA complexes. Right panel: A FRET
histogram of U-1C mutant molecules. The regular transitions between FRET = 0.5 and 0.8 are
used as a signature for identifying specific binding. (b) Nonspecific binding by CBP2 induces
large conformational fluctuations in the bI5 RNA. Left panel: FRET trajectory of a bI5 RNA
molecule in 7 mM Mg2+ and 50 nM CBP2, depicting broad and continuous fluctuations across
a wide range of FRET values (type II binding behavior). Center panel: FRET histogram
obtained from all CBP2-bI5 complexes in 7 mM Mg2+ and 50 nM CBP2. Right panel:
Autocorrelation function constructed from many FRET trajectories at 5 laser intensities (I, in
arbitrary units).
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Concentration dependence of the two CBP2 binding modes. (a) Fractions of RNA molecules
not bound to CBP2 (open circles), bound to CBP2 in the type I mode (closed squares) or the
type II mode (open triangles) as a function of CBP2 concentration. (b) Fraction of molecules
exhibiting the specific (type I) binding mode after incubation with 50 nM CBP2 for 30 min
followed by treatment with 100 μg/mL heparin for about 5 min to remove nonspecifically
bound CBP2 from the RNA. The data are fit to A[CBP2]n/([CBP2]n + Kn) with a Hill
coefficient, n = 1.3 ± 0.3.
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CBP2 induces broad structural fluctuations in diverse bI5 RNA variants. (a, b) ΔP1-P2 and
ΔP9-P9.1 constructs. The FRET histograms were constructed from many RNA molecules in
7 mM Mg2+ and 50 nM CBP2. (c) The minimum bI5 core with both P1-P2 and P9-P9.1
peripheral domains deleted. A single RNA molecule FRET trajectory in 7 mM Mg2+ and 50
nM CBP2 and A FRET histogram constructed from many molecules are shown. In all cases,
the FRET histograms of the constructs in 7 mM Mg2+ in the absence of CBP2 are overlaid for
comparison (solid lines).
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CBP2 binding destabilize RNA base pairs and causes conformational fluctuations in a RNA
hairpin. (a) RNA hairpin construct, SL1, labeled with a fluorescent Cy3 donor and Cy5
acceptor. (Top panels) The FRET histogram of the RNA hairpin indicates that most of the
molecules exhibit a well-defined FRET value with a sharp peak at 0.9 as expected for well-
formed hairpins. The small peak at FRET ∼ 0.7 may be due to a misfolded form. Upon addition
of CBP2, the FRET distribution broadens significantly due to fluctuations toward lower FRET
values. A typical trajectory showing such fluctuations is displayed in the lower panel. (b)
Control construct, SL1PC, designed to test the potential effect of dye-CBP2 interaction in
which the Cy3 and Cy5 dyes are placed on adjacent nucleotides. In this case, CBP2 does not
induce broadening of the FRET profile. For clarity, the peak at FRET = 0, reflecting inactive
or blinking Cy5 (dashed line), has been subtracted from the experimentally determined
histogram. These data were recorded in 10 mM NaCl, 10 mM HEPES pH 7.6, and the oxygen
scavenger system as described in Methods.
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CBP2 binds rapidly to the bI5 RNA with bimolecular kinetics. (a) Trajectory showing rapid
conversion of the free bI5 RNA to CBP2 bound state after addition of 50 nM CBP2 (dotted
line). (b) Number of bI5 RNA molecules bound by CBP2 as a function of time. CBP2 binding
time is scored as the time when the FRET trajectory shows the broad irregular fluctuations. A
single-exponential fit gives a binding rate of 12 min-1. The binding rate constant can also be
determined from the average FRET value for an ensemble of bI5 molecules, yielding similar
results (data not shown). (c) The binding rate constant as a function of CBP2 concentration.
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CBP2-assisted folding of bI5 occurs along multiple pathways that feature dynamic intermediate
states. Single-molecule FRET trajectory (a) and histogram (b) illustrating the structural
dynamics of a folded bI5 RNA molecule in 40 mM Mg2+ and 50 nM CBP2. A FRET histogram
for the U-1C mutant is superimposed as a black line. (c) FRET traces depicting different folding
kinetics and intermediate folding states for representative bI5 RNA molecules. The bI5 RNA
was pre-incubated at 7 mM Mg2+ prior to buffer-exchange into a folding buffer containing 40
mM Mg2+ and 50 nM CBP2 (dotted line). The upper and lower trajectories were collected at
0.5 Hz time resolution and the middle trajectory was collected at 10 Hz. The molecules often
show a dynamic ensemble of intermediates states before attaining the native state, which is
identified by a persistent high FRET state dwelling at 0.8 for at least 100 seconds except for
brief (1-2 frames) excursions to lower FRET values. Red triangles indicate the attainment of
the native state. (d) Fraction of bI5 RNA molecules folded as a function of time after adding
the folding buffer containing 40 mM Mg2+ and 50 nM CBP2. The starting conditions are 7
mM Mg2+ (circles) or 40 mM Mg2+ (squares) without CBP2. The folding kinetics at 7 mM
Mg2+ were fit to Eq. 1, yielding folding rate constants k1 = 7.2 min-1 and k2 = 0.54 min-1. The
overall fraction of molecules folded within the observation time is 65%, among which, the
fractions of molecules folded with the faster and slower rates are 47% and 53%, respectively.
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Sequential assembly model of the CBP2-bI5 RNA complex. In the absence of protein, the RNA
is predominantly in a collapsed state and exhibits transient excursions to a more structured
state with native-like features but without catalytic activity. Initial association of CBP2 with
the RNA occurs rapidly in a nonspecific mode that increases the local protein concentration
and causes substantial conformational fluctuations in the RNA. Subsequent formation of
specific CBP2-RNA interactions stabilizes the formation of the native structure of the bI5 RNA.
Helices in the bI5 RNA are represented as cylinders. View is looking down the P1 helix20.
Representative FRET trajectories for each state illustrated in the lower panel are adapted from
the data shown in Figures 3a and 9c. Note that the CBP2-bI5 RNP folds along a multitude of
pathways with distinct rate constants. In addition, a fraction of molecules misfold and do not
attain native states in the observation time window. For clarity, these complex folding kinetics
are not displayed in the model.
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